Panditharatna E, Yaeger K, Kilburn LB et al (2015) Clinicopathology of diffuse intrinsic pontine glioma and its redefined genomic and epigenomic landscape. Cancer Genet 208(7–8):367–373

Article  PubMed  Google Scholar 

Veldhuijzen van Zanten SEM, Lane A, Heymans MW et al (2017) External validation of the diffuse intrinsic pontine glioma survival prediction model: a collaborative report from the International DIPG Registry and the SIOPE DIPG Registry. J Neurooncol 134(1):231–240

Article  PubMed  PubMed Central  Google Scholar 

Kebudi R, Cakir FB (2013) Management of diffuse pontine gliomas in children: recent developments. Paediatr Drugs 15(5):351–362

Article  PubMed  Google Scholar 

Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer 11(2):85–95

Article  PubMed  CAS  Google Scholar 

Riemann A, Schneider B, Ihling A et al (2011) Acidic environment leads to ROS-induced MAPK signaling in cancer cells. PLoS ONE 6(7):e22445

Article  PubMed  PubMed Central  CAS  Google Scholar 

van Kuijk SJ, Yaromina A, Houben R et al (2016) Prognostic significance of carbonic anhydrase IX expression in cancer patients: a meta-analysis. Front Oncol 6:69

PubMed  PubMed Central  Google Scholar 

Morgan PE, Pastorekova S, Stuart-Tilley AK et al (2007) Interactions of transmembrane carbonic anhydrase, CAIX, with bicarbonate transporters. Am J Physiol Cell Physiol 293(2):C738–C748

Article  PubMed  CAS  Google Scholar 

Singh S, Lomelino CL, Mboge MY et al (2018) Cancer drug development of carbonic anhydrase inhibitors beyond the active site. Molecules 23(5):1045

Article  PubMed  PubMed Central  Google Scholar 

Lou Y, McDonald PC, Oloumi A et al (2011) Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 71(9):3364–3376

Article  PubMed  CAS  Google Scholar 

Reardon DA, Desjardins A, Vredenburgh JJ et al (2009) Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study. Br J Cancer 101(12):1986–1994

Article  PubMed  PubMed Central  CAS  Google Scholar 

Nocentini A, Supuran CT (2018) Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018). Expert Opin Ther Pat 28(10):729–740

Article  PubMed  CAS  Google Scholar 

Proescholdt MA, Mayer C, Kubitza M et al (2005) Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro Oncol 7(4):465–475

Article  PubMed  PubMed Central  CAS  Google Scholar 

Boyd NH, Walker K, Fried J et al (2017) Addition of carbonic anhydrase 9 inhibitor SLC-0111 to temozolomide treatment delays glioblastoma growth in vivo. JCI Insight 2(24):e92928

Article  PubMed  PubMed Central  Google Scholar 

Castel D, Philippe C, Calmon R et al (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130(6):815–827

Article  PubMed  PubMed Central  CAS  Google Scholar 

Meel MH, Schaper SA, Kaspers GJL et al (2018) Signaling pathways and mesenchymal transition in pediatric high-grade glioma. Cell Mol Life Sci 75(5):871–887

Article  PubMed  CAS  Google Scholar 

Pal S, Kozono D, Yang X et al (2018) Dual HDAC and PI3K inhibition abrogates NFkappaB- and FOXM1-mediated DNA damage response to radiosensitize pediatric high-grade gliomas. Cancer Res 78(14):4007–4021

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ruzzolini J, Laurenzana A, Andreucci E et al (2020) A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer. J Enzyme Inhib Med Chem 35(1):391–397

Article  PubMed  CAS  Google Scholar 

Pajovic S, Siddaway R, Bridge T et al (2020) Epigenetic activation of a RAS/MYC axis in H3.3K27M-driven cancer. Nat Commun 11(1):6216

Article  PubMed  PubMed Central  CAS  Google Scholar 

Anders S, Pyl PT, Huber W (2015) HTSeq—a Python framework to work with high-throughput sequencing data. Bioinformatics 31(2):166–169

Article  PubMed  CAS  Google Scholar 

Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1):139–140

Article  PubMed  CAS  Google Scholar 

Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545–15550

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ishida J, Alli S, Bondoc A et al (2021) MRI-guided focused ultrasound enhances drug delivery in experimental diffuse intrinsic pontine glioma. J Control Release 330:1034–1045

Article  PubMed  CAS  Google Scholar 

Vinci M, Burford A, Molinari V et al (2018) Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells. Nat Med 24(8):1204–1215

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ianevski A, He L, Aittokallio T et al (2017) SynergyFinder: a web application for analyzing drug combination dose-response matrix data. Bioinformatics 33(15):2413–2415

Article  PubMed  PubMed Central  Google Scholar 

Kutko MC, Glick RD, Butler LM et al (2003) Histone deacetylase inhibitors induce growth suppression and cell death in human rhabdomyosarcoma in vitro. Clin Cancer Res 9(15):5749–5755

PubMed  CAS  Google Scholar 

Butler LM, Webb Y, Agus DB et al (2001) Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. Clin Cancer Res 7(4):962–970

PubMed  CAS  Google Scholar 

Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 7(3):241–248

Article  PubMed  Google Scholar 

Gwak HS, Park HJ (2017) Developing chemotherapy for diffuse pontine intrinsic gliomas (DIPG). Crit Rev Oncol Hematol 120:111–119

Article  PubMed  Google Scholar 

Graham MS, Mellinghoff IK (2020) Histone-mutant glioma: molecular mechanisms, preclinical models, and implications for therapy. Int J Mol Sci 21(19):7193

Article  PubMed  PubMed Central  CAS  Google Scholar 

Lu VM, Daniels DJ (2021) Epigenetic-targeted treatments for H3K27M-mutant midline gliomas. Adv Exp Med Biol 1283:73–84

Article  PubMed  CAS  Google Scholar 

Grasso CS, Tang Y, Truffaux N et al (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21(7):827

Article